Prevalence, treatment, and control of hypertension among African Americans and Caucasians at primary care sites for medically under-served patients

Ethnicity and Disease

Volumn 15, Issue 1, 2005, Pages 25-32

  Sheats, Nina ^a   Lin, Yan ^b   Zhao, Wenle ^b   Cheek, DeAnna E ^a   Lackland, Daniel T ^b   Egan, Brent M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Control; Ethnic differences; Hypertension; Prevalence; Treatment

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CAUCASIAN; COMORBIDITY; CONSULTATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE CONTROL; DYSLIPIDEMIA; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE FACILITY; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTPATIENT; PREVALENCE; PRIMARY MEDICAL CARE; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; ANTIHYPERTENSIVE AGENTS; CHI-SQUARE DISTRIBUTION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICALLY UNDERSERVED AREA; MIDDLE AGED; PREVALENCE; PRIMARY HEALTH CARE; SOUTH CAROLINA;

EID: 14644400431     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Cooper RS, Rotimi CN, Ward R. The puzzle of hypertension in African Americans. Sci Am. 1999;280:56-63.
2. Hall WD, Ferrario CM, Moore MA, et al. Hypertension-related morbidity and mortality in the southeastern United States. Am J Med Sci. 1997;313:195-209.
3. Lackland DT, Keil JE, Gazes PC, Hames CG, Tyroler HA. Outcomes of Black and White hypertensive individuals after 30 years of follow-up. Clin Exp Hypertens. 1995;17:1091-1105.
4. Ricketts TC. The changing nature of rural health care. Annu Rev Public Health. 2000;21: 639-657.
5. Levin S, Mayer-Davis EJ, Ainsworth BE, Addy CL, Wheeler FC. Racial/ethnic health disparities in South Carolina and the role of rural locality and educational attainment. South Med J. 2001;94:711-717.
6. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199-206.
7. Shulman NB, Levinson RM, Dever GE, Porter RS, Owen SL, Hall WD. Impact of cost problems on morbidity in a hypertensive population. Am J Prev Med. 1991;7:374-377.
8. Moy E, Bartman BA, Weir MR. Access to hypertensive care: effects of income, insurance, and source of care. Arch Intern Med. 1995;155:1497-1502.
9. Ayanian JZ, Weissman JS, Schneider EC, Ginsburg JA, Zaslavsky AM. Unmet health needs of uninsured adults in the United States. JAMA 2000;284:2061-2069.
10. Weinick RM, Zuvekas SH, Cohen JW. Racial and ethnic differences in access to and use of healthcare services, 1977 to 1996. Med Care Res Rev. 2000;57(suppl 1):37-54.
11. National Center for Health Statistics. Monitoring the nation's health. Early release of selected estimates from the National Health Interview Survey (NHIS). Available at: http://www.cdc.gov/nchs/about/major/nhis/released200203.html. Accessed August 19, 2003.
12. Schneider EC, Zaslavsky AM, Epstein AM. Racial disparities in the quality of care for enrollees in Medicare managed care. JAMA. 2002;287:1288-1294.
13. Institute of Medicine Report. Unequal treatment: confronting racial and ethnic disparities in health care (March 20, 2002). Available at: http://www.iom.edu/reports.asp. Accessed March 3, 2004.
14. National Institutes of Health, NHLBI. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, Md: National Institutes of Health; November 1997. NIH Publication No. 98-4080.
15. Lackland DT, Lin Y, Tilley BC, Egan BM. Assessment of racial differences in clinical practices for hypertension at primary care sites for medically underserved patients. J Clin Hypertens. 2004;6(1):26-33.
16. Kaplan GA, Keil JE. Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation. 1993;88:1973-1998.
17. Egan BM, Lackland DT. Strategies for cardiovascular disease prevention: importance of public and community health programs. Ethn Dis. 1998;8:228-239.
18. Howard G, Howard VJ. Reasons for geographic and racial differences in stroke (REGARDS) investigators. Ethnic disparities in stroke: the scope of the problem. Ethn Dis. 2001;11:761-768.
19. Agodoa LY, Jones CA, Held PJ. End-stage renal disease in the USA: data from the United States Renal Data System. Am J Nephrol. 1996;16:7-16.
20. Douglas JG, Bakris GL, Epstein M, et al. Management of high blood pressure in African Americans. Consensus statement of the Hypertension in African Americans Working Group of the International Society of Hypertension in Blacks. Arch Intern Med. 2003;163: 525-541.
21. Lackland D, Egan B, Cheek D, Dunbar J. Racial differences in the use of office-based medical services for blood pressure assessment. Am J Hypertens. 1993;6:88A.
22. ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blockers vs diuretic: the antihypertensive and lipidlowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2002;288:2981-2997.
23. Bakris GL. A practical approach to achieving recommended blood pressure goals in diabetic patients. Arch Intern Med. 2001;161:2661-2667.
24. Cushman WC, Reda DJ, Perry HM, Williams D, Abdellatif M, Materson BJ. Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Arch Intern Med. 2000; 160:825-831.
25. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479-486.
26. Benetos A, Thomas F, Bean K, Gautier S, Smulyan H, Guize L. Prognostic value of systolic and diastolic blood pressure in treated hypertensive men. Arch Intern Med. 2002; 162:577-581.
27. Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet. 2001;358: 1304-1315.
28. Healthy People 2010. US Government Printing Office No. 017-001-00547-9. Available at: www.healthypeople.gov/publications/.
29. ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2000;283:1967-1975.
30. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypetension in the adult US population: data from the health examination surveys, 1960 to 1991. Hypertension. 1995; 26:60-69.